Dr. Ravinder Clayton, MD

Dr. Clayton practices at Banner Boswell Medical Center in Sun City, Arizona, part of Banner Health.

Dr. Clayton's NPI, 1245635747, was assigned on October 27, 2014. Dr. Clayton holds Alabama license MD.33756.

Dr. Clayton's primary practice is Banner Boswell Medical Center, at 13632 N 99th Ave, Sun City, AZ 85351 in Maricopa County. The practice phone is (623) 832-4000. Dr. Clayton also practices at Banner Boswell Medical Center, 10401 W Thunderbird Blvd, Sun City, AZ 85351.

Dr. Clayton's primary practice is Banner Boswell Medical Center in Sun City, Arizona, part of Banner Health. Dr. Clayton is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Cancer Center Specialists LLC. Dmand AI also links Dr. Clayton to 3 more hospitals, 4 medical groups, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clayton practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Clayton's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Clayton is licensed in Alabama.

CMS data shows 1,531 Medicare services from Dr. Clayton across 18 procedure codes in 2024, for 188 Medicare patients. Medicare paid $114,387 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw Dr. Clayton in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clayton's median patient age at 71, with 60% women.

In 2024, Dr. Clayton wrote 103 Medicare Part D claims for 43 patients. 95% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $487 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Clayton for performance year 2024, reported as part of a group. Dr. Clayton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clayton as offering telehealth.

Dmand AI links 6 papers to Dr. Clayton, published from 2012 to 2018. 2014 was the busiest year, with 2. The most frequent topics are Lung Neoplasms, Radiosurgery and Radiotherapy Dosage. Dr. Clayton's most frequent co-authors are Drexell H. Boggs, MD, Tyler Bryant Colvin, MD and Douglas James Minnich, MD.

CMS Open Payments shows 28 general payments to Dr. Clayton from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Siemens Medical Solutions USA, Inc. paid the most, $1,193.